false
Catalog
HRX 2024 AbstracX Library
Potential Implications of Recent Enhancements in L ...
Potential Implications of Recent Enhancements in Leadless Pacemaker Technology on Device Management
Back to course
Pdf Summary
The document discusses recent advancements in leadless pacemaker technology, specifically focusing on enhancements in battery longevity and AV synchrony, which were analyzed through a virtual patient study. The second-generation Micra pacemakers, known as Micra VR2 and AV2, demonstrate significant improvements. Notably, these enhancements are projected to reduce the need for device replacements, with Micra VR2 and AV2 associated with 8 and 15 fewer projected lifetime replacements per 100 patients, respectively. This reduction is more pronounced in pacemaker-dependent individuals and younger patients aged 65 and under, potentially avoiding the need for multiple devices over a patient's lifetime.<br /><br />The study emphasizes that the enhanced Atrial Sensing Setup in Micra AV2 devices has led to improved AV synchrony, achieving 70% AV synchrony in 90% of the tested devices. The ambulatory AV synchrony improved to 84% within the 80-100 bpm range through enhancements in the automated programming algorithm. These advancements suggest substantial savings in healthcare resource utilization, as they can potentially streamline device follow-up and reduce the frequency of device replacements.<br /><br />In addition to longevity benefits, improvements in algorithm programming have resulted in a time savings of 13 minutes per post-implant device check, according to survey results from Medtronic field representatives. This suggests further efficiencies in the management and healthcare use related to pacemaker maintenance.<br /><br />Overall, the document concludes that next-generation Micra pacemakers offer meaningful advancements in both device longevity and AV synchrony, highlighting their potential to enhance patient care and optimize healthcare resources.
Keywords
leadless pacemaker
battery longevity
AV synchrony
virtual patient study
Micra VR2
Micra AV2
device replacements
atrial sensing
algorithm programming
healthcare resources
HRX is a Heart Rhythm Society (HRS) experience. Registered 501(c)(3). EIN: 04-2694458.
Vision:
To end death and suffering due to heart rhythm disorders.
Mission:
To Improve the care of patients by promoting research, education, and optimal health care policies and standards.
© Heart Rhythm Society
1325 G Street NW, Suite 500
Washington, DC 20005
×
Please select your language
1
English